Diagnostic Value and High-Risk Factors of Two-Dimensional Ultrasonography Combined with Four-Dimensional Ultrasonography in Prenatal Ultrasound Screening of Fetal Congenital Malformations
Sign Up to like & getrecommendations! Published in 2022 at "Computational and Mathematical Methods in Medicine"
DOI: 10.1155/2022/7082832
Abstract: Objective This study mainly analyzes the diagnostic value of two-dimensional ultrasonography (2D-US) combined with four-dimensional ultrasonography (4D-US) in prenatal ultrasound screening of fetal congenital malformations (CMs) and explores the high-risk factors affecting fetal malformations. Methods… read more here.
Keywords: ultrasonography; dimensional ultrasonography; risk factors; screening fetal ... See more keywords
Gender bias in fetal malformations: A cross-sectional study in Asian populations
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Endocrinology"
DOI: 10.3389/fendo.2023.1146689
Abstract: Objectives The aim of this study was to detect any gender bias in fetal malformation cases. Design This study was a cross-sectional, quantitative survey. Subjects Overall, 1,661 Asian fetal malformation cases involving induced abortions in… read more here.
Keywords: malformation; bias fetal; gender bias; cross sectional ... See more keywords
Molecular Approaches in Fetal Malformations, Dynamic Anomalies and Soft Markers: Diagnostic Rates and Challenges—Systematic Review of the Literature and Meta-Analysis
Sign Up to like & getrecommendations! Published in 2022 at "Diagnostics"
DOI: 10.3390/diagnostics12030575
Abstract: Fetal malformations occur in 2–3% of pregnancies. They require invasive procedures for cytogenetics and molecular testing. “Structural anomalies” include non-transient anatomic alterations. “Soft markers” are often transient minor ultrasound findings. Anomalies not fitting these definitions… read more here.
Keywords: structural anomalies; meta analysis; fetal malformations; soft markers ... See more keywords
Pharmaceutical Benefits Scheme restrictions on anti‐epileptic drug prescribing promote unsafe and outdated practice
Sign Up to like & getrecommendations! Published in 2019 at "Medical Journal of Australia"
DOI: 10.5694/mja2.50246
Abstract: In May 2018, the European Medicines Agency banned the prescription of valproate to women of childbearing age for use in migraine and bipolar disorder unless they are enrolled in a special pregnancy prevention program. Its… read more here.
Keywords: risk; anti epileptic; pharmaceutical benefits; practice ... See more keywords